About Cardiology Discovery

Cardiology Discovery

Cardiology Discovery is an English-language, open-access cardiology journal based in Beijing, China. Launched at the beginning of 2021, it is the official journal of the Chinese Society of Cardiology (CSC) of the Chinese Medical Association (CMA). The journal was created to give cardiovascular research from China — and from the wider international community — a dedicated English-language platform, and to create a channel for international collaboration and exchange of cutting-edge information on cardiovascular research and education. It publishes quarterly, in print and online, through the Chinese Medical Association Publishing House in partnership with Wolters Kluwer Health and its Lippincott portfolio. Its inaugural editor-in-chief was Professor Yaling Han, a leading Chinese interventional cardiologist. The journal's official website is hosted on the Lippincott journals platform at journals.lww.com/cd.

Origins and launch

Cardiology Discovery published its inaugural issue at the beginning of 2021, with the first issue appearing in March of that year. Congratulatory editorials published in the launch issue welcomed the title as a new journal for a new era of cardiology, noting that the Chinese Medical Association Publishing House — described as the leading medical publisher in China — had launched it among several English-language journals. Because the journal is published in English, its founders presented it from the outset as a journal for the whole world rather than only for a domestic readership. The launch placed Cardiology Discovery within a broader wave of English-language specialty journals created by Chinese medical societies in the early 2021 period, designed to carry Chinese clinical and scientific work directly to international readers without translation delays.

Publisher and sponsoring society

The journal is the official journal of the Chinese Society of Cardiology of the Chinese Medical Association, and copyright in its articles is held in the name of the Chinese Medical Association, published by Wolters Kluwer Health. The Chinese Medical Association Publishing House is the publishing arm responsible for the title on the Chinese side, while Wolters Kluwer's Lippincott business provides the international publishing platform, hosting the journal alongside its large portfolio of medical titles and distributing it through services such as Ovid. This society-plus-international-publisher model is characteristic of the CMA's English-language journal programme: the society supplies the editorial community, the specialist readership and the clinical authority, while the international partner supplies production, platform and global distribution infrastructure.

Scope and subject coverage

Cardiology Discovery publishes high-quality material on all aspects of cardiovascular medicine and surgery. Its stated contents include original clinical research, epidemiological research, basic research and translational research, together with health services and outcomes studies. In practical terms this means the journal covers the full arc of modern cardiology: prevention and risk factors, diagnosis and imaging, interventional and surgical treatment, heart failure and arrhythmia care, and the laboratory science that underpins new therapies. By explicitly welcoming epidemiological and outcomes work alongside bench and clinical studies, the journal positions itself for population-level cardiovascular research — a particularly significant area for China, where cardiovascular disease is a major public-health burden — as well as for individual-patient clinical science.

Article types

The journal publishes a deliberately broad mix of article types. Alongside original research it accepts state-of-the-art reviews, technical evaluations, case reports and guideline papers. Editorials and greetings from editors of related journals appeared in its first issue, reflecting the comment and correspondence culture of a society journal. Guideline and consensus papers are a notable part of the mix: as the official journal of the Chinese Society of Cardiology, Cardiology Discovery is a natural home for society guidance and expert-consensus documents that translate evidence into practice for cardiologists. Reviews and technical evaluations help practising clinicians keep pace with devices, imaging methods and procedures, while case reports document unusual presentations and management problems from clinical practice.

Editorial leadership

The journal's inaugural editor-in-chief was Professor Yaling Han. Professor Han is a chief physician and doctoral supervisor associated with the General Hospital of Northern Theater Command, and is internationally known for work on the interventional treatment and antithrombotic therapy of complex, critical ischaemic heart disease. She has led multicentre, large-scale clinical studies including the BRIGHT, TRACK-D, I-Love-It 2 and CREATE trials, has presented at major international congresses such as those of the American College of Cardiology, the European Society of Cardiology and TCT, and has published extensively as corresponding author in leading international journals. An editor-in-chief with that profile signalled at launch that the journal intended to compete for serious clinical-trial and interventional research, not merely to serve as a house journal.

Publishing model and frequency

Cardiology Discovery is a quarterly, peer-reviewed journal; four issues appeared in its first year, 2021. It is an open-access title: articles are freely available to readers, and material in the journal is distributed under open-access terms — the launch editorial material, for example, appeared under a Creative Commons Attribution-Non Commercial-No Derivatives licence. The journal carries both a print ISSN, 2096-952X, and an electronic ISSN, 2693-8499, reflecting its dual print and online publication from Beijing. Its articles carry DOIs in the 10.1097 family associated with Wolters Kluwer's medical publishing, and the journal is read through the Lippincott website and the Ovid platform used by hospital and university libraries.

Indexing and recognition

Directory and metrics listings record Cardiology Discovery in the cardiology and cardiovascular medicine category, with coverage beginning in 2021, the year of its launch. Listings give its subject area as Cardiology and Cardiovascular Medicine and record both of its ISSNs. As a young journal founded in 2021, its bibliometric history is necessarily short: its coverage record runs from its first volume onward, and its presence in journal-ranking services reflects a title still building the citation record that older society journals have accumulated over decades. For readers assessing the journal, the more meaningful signals are institutional: official status within the Chinese Society of Cardiology, publication by the Chinese Medical Association Publishing House, and distribution by Wolters Kluwer/Lippincott.

Readership and role

The journal addresses cardiologists, cardiovascular surgeons, researchers and trainees, in China and internationally. For Chinese authors it offers something historically scarce: an English-language, society-backed cardiology journal at home, through which clinical trials, registry studies and consensus work can reach global readers directly. For international readers it offers a window into Chinese cardiovascular practice and research at a time when China contributes a growing share of the world's cardiology trials and device studies. Its stated aim — to create a platform of international collaboration and exchange of cutting-edge information on cardiovascular research and education — captures that two-way role, and its mix of research, reviews, guidelines and case reports is designed to serve both investigators and practising clinicians.

Practical information

Cardiology Discovery is published quarterly in Beijing as the official journal of the Chinese Society of Cardiology of the Chinese Medical Association, by the Chinese Medical Association Publishing House with Wolters Kluwer/Lippincott. Print ISSN: 2096-952X. Electronic ISSN: 2693-8499. The journal is in English and open access, and its official home online is the Lippincott journal site at journals.lww.com/cd, where current and past issues, article types and submission information are maintained. Readers citing the journal use the abbreviation Cardiol Discov. Anyone considering submitting work should consult the journal's own author instructions on that site, which set out its peer-review process, article categories and open-access licence terms as they stand at the time of submission.